The implications of magnetic resonance angiography artifacts caused by different types of intracranial flow diverters.


Journal

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
ISSN: 1532-429X
Titre abrégé: J Cardiovasc Magn Reson
Pays: England
ID NLM: 9815616

Informations de publication

Date de publication:
07 06 2021
Historique:
received: 11 12 2020
accepted: 06 04 2021
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 29 10 2021
Statut: epublish

Résumé

Serial cerebral angiographic imaging is necessary to ensure cerebral aneurysm occlusion after flow diverter placement. Time-of-flight (TOF)-magnetic resonance angiography (MRA) is used for this purpose due to its lack of radiation, contrast media and complications. The comparative diagnostic yield of TOF-MRA for different flow diverters has not been previously analyzed. To evaluate the diagnostic accuracy of TOF-MRA in cerebral aneurysms treated w divertersith different flow diverters. Flow-diverted patients whose cerebral follow-up MRA and digital subtraction angiograms (DSA) were obtained within 6 weeks were retrospectively identified. The DSA (as gold standard) and MRA images of these patients were compared by two readers (blinded to both patient data and endovascular procedure data) for residual aneurysms and the status of the parent artery for each type of flow diverter. In a second group of patients, magnetic susceptibility artifacts were manually measured and compared for different FDs. Seventy-six patients (85 aneurysms) were included in group one, and 86 patients (95 aneurysms) were included in group 2. TOF-MRA and DSA showed almost perfect agreement for residual aneurysms (κ = 0.88, p < 0.001) (positive predictive value (PPV) = 1.00, specificity = 1.00, negative predictive value (NPV) = 0.89, sensitivity = 0.89). Intermodality agreement (κ = 0.97 vs. κ = 0.74, p < 0.005) and sensitivity (0.97 vs. 0.77, NPV: 0.96 vs. 0.77) were highest with nitinol stents. MRA and DSA showed no agreement for occluded or stenotic parent vessels (κ = 0.13, p = 0.015, specificity = 0.44, NPV = 1.00, sensitivity = 1.00). Specificity was lower in chromium-cobalt based FDs than in nitinol devices (specificity = 0.08 vs. 0.60). Chromium-cobalt stents generated the largest artifacts (p < 0.005). The size of the device-related artifact, in millimeters, increased in respective order, for the Silk, Derivo, Pipeline and Surpass devices. Unlike DSA, TOF-MRA is susceptible to dissimilarities between flow diverters. MRA is not well-suited for research studies comparing different flow diverters. Nitinol FDs appear to be advantageous for TOF-MRA follow-up so as not to miss small aneurysm remnants or clinically relevant parent artery stenosis.

Sections du résumé

BACKGROUND
Serial cerebral angiographic imaging is necessary to ensure cerebral aneurysm occlusion after flow diverter placement. Time-of-flight (TOF)-magnetic resonance angiography (MRA) is used for this purpose due to its lack of radiation, contrast media and complications. The comparative diagnostic yield of TOF-MRA for different flow diverters has not been previously analyzed.
PURPOSE
To evaluate the diagnostic accuracy of TOF-MRA in cerebral aneurysms treated w divertersith different flow diverters.
MATERIALS AND METHODS
Flow-diverted patients whose cerebral follow-up MRA and digital subtraction angiograms (DSA) were obtained within 6 weeks were retrospectively identified. The DSA (as gold standard) and MRA images of these patients were compared by two readers (blinded to both patient data and endovascular procedure data) for residual aneurysms and the status of the parent artery for each type of flow diverter. In a second group of patients, magnetic susceptibility artifacts were manually measured and compared for different FDs.
RESULTS
Seventy-six patients (85 aneurysms) were included in group one, and 86 patients (95 aneurysms) were included in group 2. TOF-MRA and DSA showed almost perfect agreement for residual aneurysms (κ = 0.88, p < 0.001) (positive predictive value (PPV) = 1.00, specificity = 1.00, negative predictive value (NPV) = 0.89, sensitivity = 0.89). Intermodality agreement (κ = 0.97 vs. κ = 0.74, p < 0.005) and sensitivity (0.97 vs. 0.77, NPV: 0.96 vs. 0.77) were highest with nitinol stents. MRA and DSA showed no agreement for occluded or stenotic parent vessels (κ = 0.13, p = 0.015, specificity = 0.44, NPV = 1.00, sensitivity = 1.00). Specificity was lower in chromium-cobalt based FDs than in nitinol devices (specificity = 0.08 vs. 0.60). Chromium-cobalt stents generated the largest artifacts (p < 0.005). The size of the device-related artifact, in millimeters, increased in respective order, for the Silk, Derivo, Pipeline and Surpass devices.
CONCLUSION
Unlike DSA, TOF-MRA is susceptible to dissimilarities between flow diverters. MRA is not well-suited for research studies comparing different flow diverters. Nitinol FDs appear to be advantageous for TOF-MRA follow-up so as not to miss small aneurysm remnants or clinically relevant parent artery stenosis.

Identifiants

pubmed: 34092251
doi: 10.1186/s12968-021-00753-0
pii: 10.1186/s12968-021-00753-0
pmc: PMC8182930
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69

Références

J Cardiovasc Magn Reson. 2013 Jun 19;15:54
pubmed: 23782716
Stroke. 2003 Jun;34(6):1398-403
pubmed: 12775880
J Neurointerv Surg. 2019 Oct;11(10):1009-1014
pubmed: 31048457
Magn Reson Med. 2010 Apr;63(4):951-8
pubmed: 20373396
Neuroradiol J. 2015 Aug;28(4):365-75
pubmed: 26314872
Radiol Med. 2013 Sep;118(6):971-83
pubmed: 23801392
J Vasc Interv Radiol. 2001 Mar;12(3):365-71
pubmed: 11287516
Magn Reson Med. 2019 Jan;81(1):560-572
pubmed: 29893989
J Magn Reson Imaging. 2005 Dec;22(6):772-9
pubmed: 16270296
AJNR Am J Neuroradiol. 2019 May;40(5):808-814
pubmed: 31048297
Magn Reson Med. 2003 May;49(5):972-6
pubmed: 12704782
J Neurointerv Surg. 2018 Oct;10(10):988-994
pubmed: 29440326
Radiology. 2000 Oct;217(1):173-8
pubmed: 11012441
J Magn Reson Imaging. 2000 Oct;12(4):606-15
pubmed: 11042644
Stroke. 2013 Feb;44(2):442-7
pubmed: 23321438
Invest Radiol. 2001 Apr;36(4):218-24
pubmed: 11283419
Interv Neuroradiol. 2018 Dec;24(6):655-661
pubmed: 29976108
J Neuroradiol. 2015 Apr;42(2):80-5
pubmed: 25012816
AJR Am J Roentgenol. 2005 Jan;184(1):288-94
pubmed: 15615990
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
J Neurointerv Surg. 2016 Jan;8(1):81-6
pubmed: 25352582
World Neurosurg. 2016 Mar;87:317-27
pubmed: 26723288

Auteurs

Batur Halitcan (B)

Department of Radiology, Ministry of Health Ankara City Hospital, Ankara, Turkey.

Sayin Bige (S)

Department of Radiology, Ministry of Health Ankara City Hospital, Ankara, Turkey.

Balci Sinan (B)

Department of Radiology, Hacettepe University Hospitals, Ankara, Turkey.

Akmangit Ilkay (A)

Department of Radiology, Ministry of Health Ankara City Hospital, Ankara, Turkey.

Daglioglu Ergun (D)

Department of Neurosurgery, Ministry of Health Ankara City Hospital, Ankara, Turkey.

Alagoz Fatih (A)

Department of Neurosurgery, Ministry of Health Ankara City Hospital, Ankara, Turkey.

Arat Anil (A)

Department of Radiology, Hacettepe University Hospitals, Ankara, Turkey. anilarat@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH